High Quality Mirabegron Powder CAS 223673-61-8

Payment Type: L/C,T/T,Paypal
Incoterm: FOB,CIF
Min. Order: 100 Gram
Delivery Time: 3 Days

Basic Info

Model No.: CAS 223673-61-8

Additional Info

Packaging: 100g 1kg

Productivity: 1000 kg/month

Brand: chenyi

Transportation: Ocean,Land,Air

Place of Origin: China

Supply Ability: 50 kg

Certificate: ISO 9001,GMP

Port: QINGDAO,SHANGHAI

Product Description

Product name: Mirabegron

CAS NO.: 223673-61-8

MF: C21H24N4O2S

MW: 396.50

Density: 1.313

storage temp.: -20°C Freezer

Refractive index: 1.68

Appearance: White to off-white powder

Purity: More than 99.0%

Usage: Potent bladder relaxant and reagent for diabetes remedy.

 

 Specification:

Item

Specification

Result

Appearance

White crystalline powder

Complies

Related substance (HPLC)

Total impurity ≤0.5%

Max single impurity ≤0.1%

0.2%

0.06%

Odor

Characteristic

Complies

Assay

99%

99.8%

Sieve analysis

100% pass 80 mesh

Complies

Loss on Drying

Residue on Ignition

≤1.0%

≤1.0%

0.12%

0.09%

Heavy Metal

<10ppm

Complies

As

<0.1ppm

0.05ppm

Pb

<0.1ppm

0.05ppm

Cd

<0.1ppm

0.05ppm

Residual Solvents

<100ppm

Complies

Residual Pesticide

Negative

Complies

Microbiology

 

 

Total Plate Count

<1000cfu/g

Complies

Yeast & Mold

<100cfu/g

Complies

E.Coli

Negative

Complies

Salmonella

Negative

Complies

 

Functions


Myrbetriq 3 is a beta - adrenergic agonist suitable for urge incontinence, urgency, and urinary frequency symptom of overactive bladder ( OAB ) treatment.

(1) the recommended starting dose is 25 mg 1 time per day, with or without food. 

(2) 25 mg is effective within 8 weeks. Based on individual efficacy and tolerability, dose can be increased to 50 mg 1 time per day.

(3) complete with water to swallow, don't chew, split or crushed. 

(4) patients with severe renal impairment or in patients with moderate hepatic impairment, the maximum dose is 25 mg 1 time per day.

(5) have end-stage renal disease (ESRD) patients or in patients with severe hepatic impairment. Not recommended for use

 

 

Application


Use in special populations

(1) the pregnancy only if the benefit to the mother outweighs the potential risks to the fetus is only used when. 

(2) nursing mothers: Myrbetriq is expected to be excreted in human milk and nursing mothers is not recommended. 

(3) children: has not been established in children with Myrbetriq safety and effectiveness. 

(4) elderly: proposal on recommends no dose adjustment in elderly patients.


Contact Information

CONTACT US

Shandong Chenyi Environmental Protection Technology Co.,Ltd

Contact Person: Jerry

Phone:86-0531-18560179988

Fax:

Address: No.215 Beiyuan Main street,tianqiao District,Jinan,Shandong

Full name Contact Phone Content
点击刷新验证码